Ashchem Pharmacy Acquired By Juno Health

Juno Health expands in Northeast England with the sale of pharmacy chain Ashchem Chemists, strengthening its network and enhancing patient care services.

Juno Health acquires 15 pharmacies in NE England

Juno Health has expanded its footprint in Northeast England through the sale of pharmacy chain Ashchem Chemists, a well-established group of 15 pharmacies across Newcastle, Gateshead, Tyneside, and Sunderland.

This business sale brings approximately 120 experienced team members into the Juno Health network, further strengthening its commitment to providing exceptional patient care in the UK.

Leadership and Vision Behind the Expansion

Juno Health, based in Milton Keynes, is backed by an expert leadership team specialising in pharmacy and multi-site retail management. The team includes:

Mark Peatey (CEO): Over 18 years of experience in business growth across the UK, Europe, and the USA.
Rupen Sedani (Chief Pharmacy Officer): Former superintendent for Sainsbury’s 277 pharmacies.
Nick Clark (COO): 25 years of experience, including UK Retail Operations Director at Lloydspharmacy.
David Gilder (Chief Commercial Officer): Former Commercial Manager at Lloyds Chemists PLC and Sainsbury’s.
Richard Smith (Non-executive Chairman): Former MD of Lloyds Pharmacy and CEO of IDH, Europe’s largest dental care provider.

Explore more business sales

Reinventing Pharmacies Through Strategic Acquisitions

Juno Health’s mission is to reinvent family pharmacy by investing in its workforce and enhancing patient care services. By acquiring Ashchem Chemists, Juno aims to establish itself as the local pharmacy of choice, prioritising engagement, professionalism, trustworthiness, and efficiency in its operations.

CEO Mark Peatey stated:

“The Ashchem estate is one of the most respected pharmacy groups in Northern England. Ash Aggarwal built this business over 35 years with a focus on patient care and highly trained staff. We’re excited to welcome Ashchem into Juno Health and collaborate with our new colleagues to expand our pharmacy network.”

The First Step in Juno Health’s Growth Strategy

The acquisition of Ashchem Chemists marks Juno Health’s first business sale since its inception. In 2018, the company secured investment from Bregal Freshstream Capital to support its scale-up strategy.

Ashchem founder Ash Aggarwal was advised by James Pugh, with legal support from Newcastle law firm Mincoffs.

Juno Health continues to seek strategic acquisitions, reinforcing its vision to transform and modernise the pharmacy sector.

More pharmacy M&A news: Droitwich Pharmacy acquired by MSA Global

Find out how to maximise your exit

Client feedback

:I had the good fortune to work with James when I sold my chain of pharmacies, one of the top 50 in the country, in 2017.

Unlike many advisors and agents I found James to be a really refreshing change; he spent a long time listening and understanding me and we developed an excellent rapport. Its not often that your professional advisors also become friends, but our relationship is testament to the mutual respect we developed for each other.

It was clear that James' knowledge, experience and work ethic were second to none. He was always available 24/7 on the phone to support me or was quite happy to travel 6 hours to come and see me regularly. We formed an unbeatable team and we worked really well together- he was as happy to listen to me as I was to listen to him, and his input at times was crucial. His knowledge of private equity and how they work was fundamental to completing the transaction.

Honest and trustworthy with a great understanding of me and my business it was a pleasure to work with James and the outcome was superb. I thoroughly recommend anyone looking for corporate finance advice should speak with James.

Ash Aggarwal, founder

Ashchem (UK)

We'd love to hear your story

Let's chat about your future plans. We can help you get clear on where your business journey is going.

book a chat with james